368 related articles for article (PubMed ID: 24825420)
1. Assessment of insulin resistance in lean women with polycystic ovary syndrome.
Morciano A; Romani F; Sagnella F; Scarinci E; Palla C; Moro F; Tropea A; Policola C; Della Casa S; Guido M; Lanzone A; Apa R
Fertil Steril; 2014 Jul; 102(1):250-256.e3. PubMed ID: 24825420
[TBL] [Abstract][Full Text] [Related]
2. Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients.
Ciampelli M; Leoni F; Cucinelli F; Mancuso S; Panunzi S; De Gaetano A; Lanzone A
J Clin Endocrinol Metab; 2005 Mar; 90(3):1398-406. PubMed ID: 15598698
[TBL] [Abstract][Full Text] [Related]
3. Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome.
Livadas S; Kollias A; Panidis D; Diamanti-Kandarakis E
Eur J Endocrinol; 2014 Sep; 171(3):301-9. PubMed ID: 25053727
[TBL] [Abstract][Full Text] [Related]
4. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
5. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
Bahceci M; Aydemir M; Tuzcu A
Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
[TBL] [Abstract][Full Text] [Related]
6. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
[TBL] [Abstract][Full Text] [Related]
7. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.
Legro RS; Finegood D; Dunaif A
J Clin Endocrinol Metab; 1998 Aug; 83(8):2694-8. PubMed ID: 9709933
[TBL] [Abstract][Full Text] [Related]
8. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
[TBL] [Abstract][Full Text] [Related]
9. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome.
Carmina E; Lobo RA
Fertil Steril; 2004 Sep; 82(3):661-5. PubMed ID: 15374711
[TBL] [Abstract][Full Text] [Related]
10. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
Song DK; Hong YS; Sung YA; Lee H
PLoS One; 2017; 12(5):e0178120. PubMed ID: 28542421
[TBL] [Abstract][Full Text] [Related]
12. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome.
Takeuchi T; Tsutsumi O; Taketani Y
Gynecol Endocrinol; 2008 Jul; 24(7):385-91. PubMed ID: 18645711
[TBL] [Abstract][Full Text] [Related]
13. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
[TBL] [Abstract][Full Text] [Related]
14. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
15. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
16. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
[TBL] [Abstract][Full Text] [Related]
17. Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome.
Fulghesu AM; Angioni S; Portoghese E; Milano F; Batetta B; Paoletti AM; Melis GB
Fertil Steril; 2006 Aug; 86(2):398-404. PubMed ID: 16769061
[TBL] [Abstract][Full Text] [Related]
18. Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.
Stovall DW; Bailey AP; Pastore LM
J Womens Health (Larchmt); 2011 Jan; 20(1):37-43. PubMed ID: 21194310
[TBL] [Abstract][Full Text] [Related]
19. Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome.
Markou A; Androulakis II; Mourmouris C; Tsikkini A; Samara C; Sougioultzis S; Piaditis G; Kaltsas G
Fertil Steril; 2010 Mar; 93(4):1220-6. PubMed ID: 19171337
[TBL] [Abstract][Full Text] [Related]
20. Predictors of abnormal glucose metabolism in women with polycystic ovary syndrome.
Möhlig M; Spranger J; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Moltz L; Brabant G; Schöfl C
Eur J Endocrinol; 2006 Feb; 154(2):295-301. PubMed ID: 16452544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
